HCG and Accenture Partner to Pioneer AI-Powered Cancer Research and Precision Treatments in South Asia

HCG and Accenture Partner to Pioneer AI-Powered Cancer Research and Precision Treatments in South Asia

(IN BRIEF) HealthCare Global Enterprises (HCG) has partnered with Accenture to advance cancer research and treatment using cutting-edge technologies like generative AI and deep learning. This collaboration combines HCG’s oncology expertise with Accenture’s global proficiency in AI and data analytics to enhance early detection, precision medicine, and patient care. The initiative, the first of its kind in South Asia, focuses on molecular data analysis and aims to identify biomarkers and improve therapies, starting with lung adenocarcinoma and head and neck cancers. The partnership underscores a shared commitment to leveraging AI and next-gen computing for innovative cancer solutions.

(PRESS RELEASE) DUBLIN, 4-Dec-2024 — /EuropaWire/ — HealthCare Global Enterprises Limited (HCG), a leading cancer care network in India, has joined forces with Accenture to revolutionize cancer research and treatment through the integration of advanced technologies, including generative AI and deep learning. This partnership combines Accenture’s global expertise in data-driven technologies with HCG’s clinical insights in oncology to enhance early cancer detection, personalized treatments, and overall patient care.

The collaboration focuses on leveraging advanced AI tools such as image analysis software and molecular informatics to analyze multi-dimensional patient data. This initiative, the first of its kind in South Asia, will utilize Accenture’s generative AI capabilities to drive innovative research for discovering new drug targets, biomarkers, and mechanisms associated with various cancer types. Initially targeting lung adenocarcinoma and head and neck cancers, the program plans to expand its scope to include other cancer types in the future.

The partnership also aims to deepen understanding of cancer development, symptoms, and origins to create new treatment algorithms and precision medicine approaches. Advanced computing, including AI, cloud technologies, machine learning, and quantum computing, will underpin efforts to improve clinical decision-making, develop targeted therapies, and increase the efficiency of patient care.

Dr. B. S. Ajaikumar, Executive Chairman of HCG, emphasized the importance of technology-driven advancements in cancer research. “AI-powered innovation is transforming cancer care, enabling precision treatments and activating new possibilities with established therapies. This collaboration with Accenture reinforces our commitment to leveraging disruptive technologies to deliver patient-centric solutions and outcomes,” he said.

Senthil Ramani, Accenture’s Global Lead of Data and AI, highlighted the potential of next-generation technologies to address critical needs in healthcare. “By merging generative AI with biological and clinical expertise, this partnership aims to improve decision-making in cancer care, benefiting patients in South Asia and globally,” Ramani noted.

HCG, headquartered in Bengaluru, operates a network of 22 comprehensive cancer centers across India and Africa, providing state-of-the-art diagnostic and treatment solutions. This collaboration with Accenture underscores HCG’s commitment to advancing oncology care through innovation and cutting-edge technology.

About HealthCare Global Enterprises Ltd.
HealthCare Global Enterprises Ltd. (HCG), headquartered in Bengaluru, is the largest provider of cancer care in India. Through its network of 22 comprehensive cancer centers across India and Africa, HCG has brought advanced cancer care to the doorstep of millions of people. HCG’s comprehensive cancer centers provide expertise and advanced technologies for the effective diagnosis and treatment of cancer under one roof. Under the “Milann” brand, HCG operates 7 fertility centers. https://www.hcgoncology.com/.

About Accenture
Accenture is a leading global professional services company that helps the world’s leading organizations build their digital core, optimize their operations, accelerate revenue growth and enhance services—creating tangible value at speed and scale. We are a talent- and innovation-led company with 774,000 people serving clients in more than 120 countries. Technology is at the core of change today, and we are one of the world’s leaders in helping drive that change, with strong ecosystem relationships. We combine our strength in technology and leadership in cloud, data and AI with unmatched industry experience, functional expertise and global delivery capability. Our broad range of services, solutions and assets across Strategy & Consulting, Technology, Operations, Industry X and Song, together with our culture of shared success and commitment to creating 360° value, enable us to help our clients reinvent and build trusted, lasting relationships. We measure our success by the 360° value we create for our clients, each other, our shareholders, partners and communities. Visit us at accenture.com.

Media Contact:

Liza Saha
Accenture
+91 9871966466
liza.saha@accenture.com

SOURCE: Accenture